Title : Global Erectile Dysfunction Market 2016-2020 With Bayer, Boston Scientific, Coloplast, Eli Lilly & Pfizer Dominating - Research and Markets
URL Link : Global Erectile Dysfunction Market 2016-2020 With Bayer, Boston Scientific, Coloplast, Eli Lilly & Pfizer Dominating - Research and Markets
Global Erectile Dysfunction Market 2016-2020 With Bayer, Boston Scientific, Coloplast, Eli Lilly & Pfizer Dominating - Research and Markets
The analysts forecast the world erectile dysfunction treatment target witness time consuming growth in market height and width of USD 4.08 billion through the period 2016-2020.
The lack of erection may be attributed to various factors including high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or vertebrae damage, and low testosterone levels. The condition might be treated using a broad range of medicine and implants available for sale.
The report covers the current scenario along with the growth prospects of the worldwide erectile dysfunction treatment industry for 2016-2020. To calculate this market size, the report considers the revenue generated on the sales of several types of penile implants, ED creams, and drugs, including branded and generic drugs. The report also may include a discussion in the key vendors operating with this market.
Key questions answered in this particular report
What will the marketplace size stay in 2020 and after that the growth rate be?
What are definitely the key market trends?
What is driving forex trading?
What include the challenges to advertise growth?
Who would be the key vendors on this market space?
What are industry opportunities and threats faced through the key vendors?
What include the strengths and weaknesses on the key vendors?
Key vendors
Bayer
Boston Scientific
Coloplast
Eli Lilly
Pfizer
Other prominent vendors
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope with the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by kind of ED drugs
Part 08: Market segmentation by kind of ED device
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more info about this report visit http://www.researchandmarkets.com/research/68q7pn/global_erectile
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Erectile dysfunction affects an estimated 18 million men in the U.S. alone
Now, You're reading Global Erectile Dysfunction Market 2016-2020 With Bayer, Boston Scientific, Coloplast, Eli Lilly & Pfizer Dominating - Research and Markets with url link:https://niddk.blogspot.com/2016/10/global-erectile-dysfunction-market-2016.html
0 comments:
Post a Comment